disodium cantharidin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Y; Ding, J; Feng, J; Gong, Q; Hu, S; Li, X; Liu, H; Liu, S; Tan, Z; Tang, F; Wang, C; Xiao, Z; Zhou, M | 1 |
| Cui, J; Wang, B | 1 |
1 review(s) available for disodium cantharidin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cantharidin; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2019 |
1 trial(s) available for disodium cantharidin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Treatment of mid-late stage NSCLC using sodium cantharidinate/vitamin B6/GP regimen in clinic.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cantharidin; Carcinoma, Non-Small-Cell Lung; China; Drug-Related Side Effects and Adverse Reactions; Humans; Neoplasm Staging; Quality of Life; Treatment Outcome; Vitamin B 6 | 2014 |